While treatment of an IAPi AT406 alone slightly slowed down the growth of the LKB1-KO CMT167 tumor as compared to the DMSO control, the combination of AT406 with anti-PD1 lead to a significant synergistic anti-tumor effect (Supplementary Fig. S11H). Here, STK11 is linked to neoplasm.